646
Views
1
CrossRef citations to date
0
Altmetric
Oncology

LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab

, , , &
Article: 2257227 | Received 19 Jun 2023, Accepted 06 Sep 2023, Published online: 15 Sep 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.